Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital Heidelberg
NRG Oncology
EBG MedAustron GmbH
University Hospital Heidelberg
Emory University
Emory University
NRG Oncology
Massachusetts General Hospital
Emory University
Proton Collaborative Group
Emory University
Technische Universität Dresden
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Shanghai Proton and Heavy Ion Center
Hospices Civils de Lyon